462 related articles for article (PubMed ID: 18853040)
1. Purinergic signalling: past, present and future.
Burnstock G
Braz J Med Biol Res; 2009 Jan; 42(1):3-8. PubMed ID: 18853040
[TBL] [Abstract][Full Text] [Related]
2. Purinergic signalling: Its unpopular beginning, its acceptance and its exciting future.
Burnstock G
Bioessays; 2012 Mar; 34(3):218-25. PubMed ID: 22237698
[TBL] [Abstract][Full Text] [Related]
3. Purinergic signalling: pathophysiology and therapeutic potential.
Burnstock G
Keio J Med; 2013; 62(3):63-73. PubMed ID: 24067872
[TBL] [Abstract][Full Text] [Related]
4. Introduction to Purinergic Signaling.
Burnstock G
Methods Mol Biol; 2020; 2041():1-15. PubMed ID: 31646477
[TBL] [Abstract][Full Text] [Related]
5. Purinergic signalling.
Burnstock G
Br J Pharmacol; 2006 Jan; 147 Suppl 1(Suppl 1):S172-81. PubMed ID: 16402102
[TBL] [Abstract][Full Text] [Related]
6. Historical review: ATP as a neurotransmitter.
Burnstock G
Trends Pharmacol Sci; 2006 Mar; 27(3):166-76. PubMed ID: 16487603
[TBL] [Abstract][Full Text] [Related]
7. Purinergic signalling: from normal behaviour to pathological brain function.
Burnstock G; Krügel U; Abbracchio MP; Illes P
Prog Neurobiol; 2011 Oct; 95(2):229-74. PubMed ID: 21907261
[TBL] [Abstract][Full Text] [Related]
8. Introduction to Purinergic Signalling in the Brain.
Burnstock G
Adv Exp Med Biol; 2020; 1202():1-12. PubMed ID: 32034706
[TBL] [Abstract][Full Text] [Related]
9. Introductory overview of purinergic signalling.
Burnstock G
Front Biosci (Elite Ed); 2011 Jun; 3(3):896-900. PubMed ID: 21622101
[TBL] [Abstract][Full Text] [Related]
10. Introduction to purinergic signalling in the brain.
Burnstock G
Adv Exp Med Biol; 2013; 986():1-12. PubMed ID: 22879061
[TBL] [Abstract][Full Text] [Related]
11. Physiology and pathophysiology of purinergic neurotransmission.
Burnstock G
Physiol Rev; 2007 Apr; 87(2):659-797. PubMed ID: 17429044
[TBL] [Abstract][Full Text] [Related]
12. Overview. Purinergic mechanisms.
Burnstock G
Ann N Y Acad Sci; 1990; 603():1-17; discussion 18. PubMed ID: 1981306
[TBL] [Abstract][Full Text] [Related]
13. Potential therapeutic targets in the rapidly expanding field of purinergic signalling.
Burnstock G
Clin Med (Lond); 2002; 2(1):45-53. PubMed ID: 11871639
[TBL] [Abstract][Full Text] [Related]
14. Purinergic signalling--an overview.
Burnstock G
Novartis Found Symp; 2006; 276():26-48; discussion 48-57, 275-81. PubMed ID: 16805422
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology of astroglial purinergic signalling.
Franke H; Verkhratsky A; Burnstock G; Illes P
Purinergic Signal; 2012 Sep; 8(3):629-57. PubMed ID: 22544529
[TBL] [Abstract][Full Text] [Related]
16. Physiopathological roles of P2X receptors in the central nervous system.
Burnstock G
Curr Med Chem; 2015; 22(7):819-44. PubMed ID: 25005189
[TBL] [Abstract][Full Text] [Related]
17. The journey to establish purinergic signalling in the gut.
Burnstock G
Neurogastroenterol Motil; 2008 May; 20 Suppl 1():8-19. PubMed ID: 18402638
[TBL] [Abstract][Full Text] [Related]
18. ATP- and adenosine-mediated signaling in the central nervous system: adenosine receptor activation by ATP through rapid and localized generation of adenosine by ecto-nucleotidases.
Matsuoka I; Ohkubo S
J Pharmacol Sci; 2004 Feb; 94(2):95-9. PubMed ID: 14978343
[TBL] [Abstract][Full Text] [Related]
19. Purinergic Signalling and Neurological Diseases: An Update.
Burnstock G
CNS Neurol Disord Drug Targets; 2017; 16(3):257-265. PubMed ID: 27658510
[TBL] [Abstract][Full Text] [Related]
20. Unresolved issues and controversies in purinergic signalling.
Burnstock G
J Physiol; 2008 Jul; 586(14):3307-12. PubMed ID: 18499722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
